Acusphere

Speciality pharmaceutical company developing cardiovascular drugs for the detection of coronary artery disease.

Launch date

1993

Employees

Market cap

Enterprise valuation

AUD5m (Public information from Sep 2024)

Lexington Kentucky (HQ)

Date	Investors	Amount	Round
-	Western Technology Investment	N/A	-
Apr 2003	Polaris Partners BancBoston Ventures Thomas Weisel Partners Audax Ventures Technology Funding HBM Healthcare Investments	$19.0m	Late VC
Oct 2003	N/A	N/A	IPO
Jul 2011	N/A	$7.5m	Early VC
Feb 2012	N/A	$2.5m	Debt
Sep 2019	N/A	$100k	Convertible
Total Funding		AUD41.1m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Acusphere